Kevin Ho, PharmD candidate


Abrocitinib for Atopic Dermatitis

The drug’s approval was based on the results of 3 clinical trials.

Quinn Everts


What Is The Link Between Antidepressants and Hospital-Acquired Clostridium Difficile Infection?

Researchers found an increased occurrence of CDI in individuals who were prescribed antidepressants.

Maxim Mikheev, PhD, MD, MSc


How Rare Cannabinoids Are Disrupting the Pharmaceutical Industry

By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.

Frank Diamond


FDA Issues EUA for First Oral Antiviral Pill for COVID-19

The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.

Erin O'Brien


NJ and CO Governors Partner to Support Youth Mental Health

United States leaders work together to create bipartisan solutions for the youth mental health crisis.

Amanda Clouser, PharmD


Review: Harmful Excipients for Pediatric Patients

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.

Megan Wright, CPhT-Adv


Pharmacy Technicians Provide Patient Assistance With Oral Oncolytics

Pharmacy technicians can provide a great amount of value for patients navigating the financial toxicity of cancer treatment.

Julia Bonavitacola


Interactive Risk Ratio Simulation Abates Vaccine Hesitancy

Vaccine-hesitant adults were more likely to show positive change in opinion after being presented with an interactive risk ratio simulation according to a new study.

Catherine Y. Spong, MD


Protecting Our Most Vulnerable Through Vaccination

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.

Olivia G. Funk, PharmD Candidate


Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common Cold

Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.

Shams Alrubaie, PharmD Candidate


New Advances in Breast Cancer Therapy

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.

David Hutton


Two Eye Diseases Could Contribute to Common Blinding Eye Condition

The study could lead to early diagnosis and treatment of age-related macular degeneration.

Ollin Sykes, CPA, CITP


Focus on DIR Fees: 3 Ways to Manage Them

When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.

Bonnie Bond, CPA


Maximizing Adherence Packaging for Patient Health and Pharmacy Growth

Is adherence packaging technology a big investment for a community or independent pharmacy?

Carrie W. Nemerovski, PharmD


OTC Drug Interaction Considerations in the Cough and Cold Aisle

OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.

Ariana Pelosci


Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference Product

Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.

Thomas W. Laudone, PharmD, BCPPS


Case Study: Treating Infants for Cannabis Exposure

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.

Rachel H. Alinsky, MD, MPH


Cannabinoid Hyperemesis Syndrome: Diagnosis and Management

A deep dive for pharmacists into this frequently debilitating disorder

Katie Hobbins


Creating A Successful Social Media Presence

Social media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.

Matthew Fowler


COVID-19 Vaccines: T Cell, Antibody Responses Demonstrated in CLL

Patients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.

Oriana Lerner


Breaking Down the Numbers for Isotretinoin AEs

Recent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.

Maggie L. Shaw


Increase Seen in Eczema, Prevalence Varies by Race and Ethnicity

Previous surveys suggested care disparities. Investigators compared these outcomes because of a lack of research in this space.

Robert Calandra


Why Is There Such A Large Disparity In Who Meets Critera For Hepatitis B Treatment?

Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.

Madeleine Depinho, BS, PharmD Candidate 2022


New Drug Review: Atogepant FDA-Approved for Migraine Treatment

On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES


Basal Insulin Therapies for Diabetes Management

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Thomas C. Blevins, MD, ECNU, FACE, FNLA, review FDA-approved basal insulins for the management of diabetes.

Egla Hasimllari, PharmD Candidate


Vivjoa Approved for Recurrent Vulvovaginal Candidiasis

Oteseconazole is a treatment option for those living with a previously unmet medical need.

Tom Knight, MBA, MS


Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget Cuts

With the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.

Tracy D Mahvan, RPh, PharmD, MBA, BCGP


OTC Considerations for COVID-19

Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves

Kathy Blanchard


Focus on DIR Fees: 3 Ways to Manage Them

When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.

© 2023 MJH Life Sciences

All rights reserved.